# A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

> **NCT02741245** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 321 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe 10 mg
- **DRUG:** Rosuvastatin 2.5 mg
- **DRUG:** Placebo for Ezetimibe
- **DRUG:** Placebo for Rosuvastatin

## Key facts

- **NCT ID:** NCT02741245
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-09
- **Primary completion:** 2017-01-18
- **Final completion:** 2017-01-18
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02741245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02741245, "A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02741245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*